South Africa Infection Control Market - Forecasts from 2020 to 2025
South Africa infection control market is estimated to grow at a CAGR of 7.37% by the end of 2025. The market in South Africa is projected to grow at a fast rate due to the prevalence of communicable and non-communicable diseases. The substantial utilization of public healthcare facilities is further driving market demand. Furthermore, with the provision of equitable access to tertiary healthcare services in the country, the market for infection control is estimated to strengthen in the forecast period and in the upcoming years. Additionally, the presence of major market players manufacturing innovative infection control products including sterilizers, disinfectants, and many more for consumption in the South African region are contributing to market growth over the next five years. With the growing geriatric population in the country, the focus is shifting towards programs that support the decline of deaths caused by diseases like cardiac disease and diabetes, especially for population 65 years of age or more. Such initiatives are further poised to provide an opportunity for the market to grow at a sustainable pace in the forecast period and in the upcoming years.
The impartial access to specialized tertiary healthcare services is propagating the market demand in the forecast period.
The highly specialized healthcare services that are exclusively hospital-based services require strong coordination from the government owing to the unequal distribution across the country. Hence, several patients are receiving medical care in their neighbouring provinces in case of non-availability of these services in their home community. The South African Department of Health (DoH) provides subsidies to 29 tertiary hospitals via the national territory services grant ensuring that the provincial departments treating patients from other provinces are adequately funded for their activities. The funding covers medical specialists, equipment, advanced medical investigation and advanced treatments as per the approved service specifications.
The growing geriatric population in the country is surging the market demand in the forecast period.
According to Statistics South Africa, in 2017, it was indicated that the elderly (60 years or older) population size is increasing, this achieved a percent share of 8.1% of the total population. As per the stats, the estimated geriatric population in the same year was predicted to be 4.6 million. The regional variations of ageing in the country are as follows: almost a quarter of the elderly people were living in Gauteng accounting to hold a share of 7.7% of the total Gauteng population. On the other hand, around 12% of the aging people were residing in the Eastern Cape. Mpumalanga’s population consists of 7% geriatric, which was considered the lowest among the provinces.
Between 2002 and 2017, the proportion of the geriatric population among the black Africans rose by 0.5% among the others, it increased by 2.7%. The elderly population among the Indians/Asians were increased by 4.2% and among the whites, this was estimated to increase by 7.3%.
The health programs dedicated to HIV contributed to a decrease in the number of deaths related to communicable diseases such as HIV and tuberculosis. The focus is now being shifted towards the treatment of non-communicable diseases which include heart disorders and diabetes, specifically for individuals that are aged 65 years of age or more.
Segmentation:
The impartial access to specialized tertiary healthcare services is propagating the market demand in the forecast period.
The highly specialized healthcare services that are exclusively hospital-based services require strong coordination from the government owing to the unequal distribution across the country. Hence, several patients are receiving medical care in their neighbouring provinces in case of non-availability of these services in their home community. The South African Department of Health (DoH) provides subsidies to 29 tertiary hospitals via the national territory services grant ensuring that the provincial departments treating patients from other provinces are adequately funded for their activities. The funding covers medical specialists, equipment, advanced medical investigation and advanced treatments as per the approved service specifications.
The growing geriatric population in the country is surging the market demand in the forecast period.
According to Statistics South Africa, in 2017, it was indicated that the elderly (60 years or older) population size is increasing, this achieved a percent share of 8.1% of the total population. As per the stats, the estimated geriatric population in the same year was predicted to be 4.6 million. The regional variations of ageing in the country are as follows: almost a quarter of the elderly people were living in Gauteng accounting to hold a share of 7.7% of the total Gauteng population. On the other hand, around 12% of the aging people were residing in the Eastern Cape. Mpumalanga’s population consists of 7% geriatric, which was considered the lowest among the provinces.
Between 2002 and 2017, the proportion of the geriatric population among the black Africans rose by 0.5% among the others, it increased by 2.7%. The elderly population among the Indians/Asians were increased by 4.2% and among the whites, this was estimated to increase by 7.3%.
The health programs dedicated to HIV contributed to a decrease in the number of deaths related to communicable diseases such as HIV and tuberculosis. The focus is now being shifted towards the treatment of non-communicable diseases which include heart disorders and diabetes, specifically for individuals that are aged 65 years of age or more.
Segmentation:
- By Product
- Disinfectant
- Sterilization
- Low temperature Sterilization
- Heat Sterilization
- Contract Sterilization
- By End User Industry
- Healthcare
- Food and Beverage
- Chemical
1. INTRODUCTION
1.1. Market Definition
1.2. Market Segmentation
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Market Opportunities
4.4. Porters Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitutes
4.4.5. Competitive Rivalry in the Industry
4.5. Industry Value Chain Analysis
5. SOUTH AFRICA INFECTION CONTROL MARKET ANALYSIS, BY PRODUCT
5.1. Introduction
5.2. Disinfectant
5.3. Sterilization
5.3.1. Low Temperature Sterilization
5.3.2. Heat Sterilization
5.3.3. Contract Sterilization
6. SOUTH AFRICA INFECTION CONTROL MARKET ANALYSIS, BY END USER INDUSTRY
6.1. Introduction
6.2. Healthcare
6.3. Food and Beverage
6.4. Chemical
7. COMPETITIVE ENVIRONMENT AND ANALYSIS
7.1. Major Players and Strategy Analysis
7.2. Emerging Players and Market Lucrativeness
7.3. Mergers, Acquisitions, Agreements, and Collaborations
7.4. Vendor Competitiveness Matrix
8. COMPANY PROFILES
8.1. 3M
8.2. STERIS plc
8.3. Becton, Dickinson and Company
8.4. Getinge AB
8.5. B. Braun Melsungen AG
8.6. List is not Exhaustive*
1.1. Market Definition
1.2. Market Segmentation
2. RESEARCH METHODOLOGY
2.1. Research Data
2.2. Assumptions
3. EXECUTIVE SUMMARY
3.1. Research Highlights
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Market Opportunities
4.4. Porters Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitutes
4.4.5. Competitive Rivalry in the Industry
4.5. Industry Value Chain Analysis
5. SOUTH AFRICA INFECTION CONTROL MARKET ANALYSIS, BY PRODUCT
5.1. Introduction
5.2. Disinfectant
5.3. Sterilization
5.3.1. Low Temperature Sterilization
5.3.2. Heat Sterilization
5.3.3. Contract Sterilization
6. SOUTH AFRICA INFECTION CONTROL MARKET ANALYSIS, BY END USER INDUSTRY
6.1. Introduction
6.2. Healthcare
6.3. Food and Beverage
6.4. Chemical
7. COMPETITIVE ENVIRONMENT AND ANALYSIS
7.1. Major Players and Strategy Analysis
7.2. Emerging Players and Market Lucrativeness
7.3. Mergers, Acquisitions, Agreements, and Collaborations
7.4. Vendor Competitiveness Matrix
8. COMPANY PROFILES
8.1. 3M
8.2. STERIS plc
8.3. Becton, Dickinson and Company
8.4. Getinge AB
8.5. B. Braun Melsungen AG
8.6. List is not Exhaustive*
